Watch for Changes in 2002

At The Scientist, we try to make incremental improvements in our publication every issue. The improvements may include spending extra time editing stories to make them easier to read, or calling additional sources to procure artwork to properly illustrate an article. A 24-times-a-year publication schedule leaves little leeway between issues to make major changes, but we still keep our sights set on making each issue better than the last. Now, after this, our final issue of 2001, we really have

Written byLarry Hand
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Now, after this, our final issue of 2001, we really have our work cut out for us. Our incremental charge has become monumental. For Jan. 7, 2002, we have ambitious plans that include changing our format from tabloid size to standard magazine size and adding new elements to the content. We're also broadening our scope of coverage because we're now going to distribute our publication in print in Europe and Canada, as well as in the United States. So, when you receive your next issue of The Scientist, watch for some major improvements.

First, look for a smaller, more convenient page size, 8 1/4 x 10 1/2 inches. We'll still have the familiar sections of the publication--News, Research, LabConsumer, Profession--but they will be presented in an updated, reader-friendly, and colorful design. And because the page size will be smaller, we will be publishing a greater number of pages to continue ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies